Wyniki paliatywnej teleradioterapii chorych na niedrobnokomórkowego raka pluca
Author(s): Tomasz Walasek, Marian Reinfuss, Jerzy Jakubowicz, Piotr Skotnicki, Pawel Blecharz, Magdalena PÄ?cak, Tomasz DÄ?browski
We present analysis of literature data on survival of patients with advanced NSCLC (non-small cell lung cancer) after palliative chest teleradiotherapy. We found that the average survival rate in this group of patients was between 4 to 12 months. One-year survival rate was from 14 to 49 % two-year survival rate 3 - 17 % and three-year survival rate 2 - 8 %. We found that differences in survival result mainly from heterogeneous patients groups. We discussed the controversial problem of influence of palliative chest teleradiotherapy on the overall survivals of patients with advanced NSCLC.
Share this article
Submitted PhD thesis in Biotechnology at GITAM University, Vizag.
The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
Saudi Arabia Critical Care/TPN
Clinical Pharmacist Ministry of Health,
Riyadh, Saudi Arabia.
Department of Radiation Oncology
Asahi University Hospital
Gifu city, Gifu, Japan
Maher Abdel Fattah Al-Shayeb
Department of Surgical Sciences, Ajman University, UAE
Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)
Citations : 61
- Euro Pub
- Google Scholar
- Medical Project Poland
- Cancer Index
- Gdansk University of Technology, Ministry Points 20